Analysis of factors predicting the response to tolvaptan in patients with liver cirrhosis and hepatic edema

Background and Aim This study aimed to clarify the factors predictive of treatment response to tolvaptan (V2‐receptor antagonist) for cirrhotic patients with hepatic edema in a real‐world setting. Methods In this retrospective, multicenter study, tolvaptan was orally administered at a dose of 7.5 mg...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of gastroenterology and hepatology 2018-06, Vol.33 (6), p.1256-1263
Hauptverfasser:	Atsukawa, Masanori, Tsubota, Akihito, Kato, Keizo, Abe, Hiroshi, Shimada, Noritomo, Asano, Toru, Ikegami, Tadashi, Koeda, Mai, Okubo, Tomomi, Arai, Taeang, Nakagawa‐Iwashita, Ai, Yoshida, Yuji, Hayama, Korenobu, Itokawa, Norio, Kondo, Chisa, Chuganji, Yoshimichi, Matsuzaki, Yasushi, Iwakiri, Katsuhiko
Format:	Artikel
Sprache:	eng
Schlagworte:	blood urea nitrogen Body weight Cirrhosis diuretics Edema Excretion hepatic edema Liver Liver cirrhosis Multivariate analysis Oral administration Patients Sodium tolvaptan Urea Urine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!